Statistics for Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer's disease

Total visits

views
Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer's disease 13

Total visits per month

views
May 2024 0
June 2024 1
July 2024 2
August 2024 2
September 2024 1
October 2024 1
November 2024 0

File Visits

views
hamann_design_2018.pdf 96